Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke

Kurtzke JF, 1982, Neurology, 32, 1207, 10.1212/WNL.32.11.1207

10.1002/(SICI)1097-4598(1997)6+<21::AID-MUS4>3.0.CO;2-L

Simpson DM, 1996, Neurology, 46, 1306, 10.1212/WNL.46.5.1306

10.1177/026921559701100102

Bakheit AMO, 1996, Crit Rev Phys Rehabil Med, 8, 235, 10.1615/CritRevPhysRehabilMed.v8.i3.50

10.1097/00002060-200007000-00010

10.1191/026921500666642221

10.1016/S0885-3924(00)00146-9

10.1136/jnnp.69.2.217

Ashworth B, 1964, Practitioner, 192, 540

10.1002/(SICI)1097-4598(1997)6+<208::AID-MUS15>3.0.CO;2-1

Childers MK, 1999, Neurology, 52, A295

10.1001/jama.270.20.2475

10.1007/PL00007848

Hatheway CL, Dang C. Immunogenicity of the neurotoxins of Clostridium botulinum. In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994:93-107.

10.1136/jnnp.69.4.499

Young RR, 1994, Neurology, 44, S12

10.1161/01.STR.31.10.2402

Klaiman MD, 1997, Trauma, 39, 33

Gormley ME, 1997, Muscle Nerve Suppl, 6, S14, 10.1002/(SICI)1097-4598(1997)6+<14::AID-MUS3>3.0.CO;2-M

Landau WM, 1974, Arch Neurol, 31, 217, 10.1001/archneur.1974.00490400031001

Gordon MF, 2002, Neurology, 58, A221